Zoxus Global

Investors

Careers

NEFOPAM

IUPAC Name: 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine

Molecular Formula: C17H19NO

Molecular weight: 253.34 g/mol

CAS No: 13669-70-0

ATC Code: N02BG06

Drug Class: NSAID

General Properties:

5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine is a member of the class of benzoxazocines that is 3,4,5,6-tetrahydro-1H-2,5-benzoxazocine substituted by phenyl and methyl groups at positions 1 and 5 respectively. It is a benzoxazocine and a tertiary amino compound.

Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.

Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain.

Indication:

Nefopam is licensed for pain relief in acute and chronic pain. The recommended starting dose is 30mg to 60mg three times a day. This can be increased to a maximum of 90mg three times a day

Related Products